Financial Impact of FMS HS

“In Business Everyday is Game Day”

The burden of musculoskeletal conditions is significant in terms of treatment and care. This also impacts ones quality of life, mobility, and productivity, which results in higher numbers of missed days at work. In 2011, the annual U.S. cost for treatment and lost wages related to musculoskeletal disorders was $213 billion. When adding the burden of other conditions affecting persons with musculoskeletal conditions such as diabetes, heart disease and obesity, the total indirect and direct costs rose to $874 billion, or 5.7 percent of the GDP in 2015. Other data on the costs of musculoskeletal diseases and injuries includes:

  • 18% of all health care visits in 2010 were related to musculoskeletal conditions, including 52 million visits for low back pain, and 66 million for bone and joint injuries.
  • The average annual cost per person for treatment of a musculoskeletal condition is $7,800.
  • The estimated annual cost for medical care to treat all forms of arthritis and joint pain was $580.9 billion, which represented a 131 percent increase (in 2011 dollars) over 2000.
  • In 2012, 25.5 million people lost an average of 11.4 days of work due to back or neck pain, for a total of 290.8 million lost workdays in 2012 alone.

Opportunities for Change

There are tremendous economic and societal approaches for employees and employers working together to take a proactive approach musculoskeletal disorders, including:

  • Using proven strategies from our industry with data collection to drive movement and behavioral change (FMS has been used in sports for years).
  • Improving understanding of the role of behavior change in prevention and treatment, including weight loss and self-management of conditions once they arise.
  • Implementing proven prevention strategies for sports injuries, workplace injuries, and injuries in the military.
  • Ensuring that health care providers, especially primary care physicians, have the appropriate training to diagnose, and if necessary, refer patients for appropriate treatment.
  • Addressing data limitations, and improve systems, to improve our understanding of these conditions and how best to screen, diagnose and treat them.